Clinical Trials Directory

Trials / Completed

CompletedNCT04779099

Trial of a Brief Psychological Intervention for Suicidal Patients with Borderline Personality Disorder in the Emergency Department

Pilot Randomized Controlled Trial of a Brief Psychological Intervention for Suicidal Patients with Borderline Personality Disorder in the Emergency Department

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Centre for Addiction and Mental Health · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

When in crisis, people with borderline personality disorder (BPD) frequently seek care in emergency departments (EDs) often presenting with suicide and self-harm behaviour. There is no established evidence-based brief intervention for patients with BPD in ED settings, however a 4-session psychotherapeutic intervention for people with personality disorders in ED settings was tested in Australia and showed promising results in reduced health care utilization. The proposed pilot randomized controlled trial will assess the feasibility of delivering this 4-session intervention in the ED for people with BPD who present with suicidal ideation or self-harm with the aim of reducing health care utilization.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBrief 4-session intervention for borderline personality disorderIntervention consists of weekly 50-minute 1:1 sessions focused on psycho-education, here-and-now problem solving and safety planning. One of the sessions can involve a significant other to provide psychoeducation about the disorder and to facilitate support. This intervention is detailed in a published manual.
BEHAVIORALTreatment as usualTAU comprises access to psychiatric assessment, medication review, and unscheduled sessions with allied health professionals using a drop-in model of care.

Timeline

Start date
2021-10-22
Primary completion
2023-05-24
Completion
2023-05-24
First posted
2021-03-03
Last updated
2024-12-04

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04779099. Inclusion in this directory is not an endorsement.